Evidence map›Paper›PMID 40224436›Full record

ArticleACS omega2025

Integrated Network Pharmacology, Molecular Modeling, LC-MS Profiling, and Semisynthetic Approach for the Roots of

Alaa A El-Banna, Enas E Eltamany, Asmaa S A Yassen, Ahmed Lotfy, Aya H H El-Tanahy, Jihan M Badr, Mardi M Algandaby, Samar S Murshid, Sameh S Elhady, Reda F A Abdelhameed

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Linking phytochemistry to bioactivity:Frontiers in chemistry · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alaa A El-BannaDepartment of Pharmacognosy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.
Enas E EltamanyDepartment of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.
Asmaa S A YassenDepartment of Medicinal Chemistry, Faculty of Pharmacy, Galala University, New Galala 43713, Egypt.ORCID https://orcid.org/0000-0002-7956-9739
Ahmed LotfyEgyptian Liver Research Institute and Hospital (ELRIAH), Mansoura 35111, Egypt.
Aya H H El-TanahyDepartment of Pharmacognosy, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa 7730103, Egypt.
Jihan M BadrDepartment of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.
Mardi M AlgandabyDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Samar S MurshidDepartment of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID https://orcid.org/0000-0002-9370-4546
Sameh S ElhadyDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID https://orcid.org/0000-0003-3799-0581
Reda F A AbdelhameedDepartment of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40224436
PMCPMC11983213

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.